Hospital for Special Surgery Shoulder Arthroplasty Cohort
Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement: HSS Shoulder Arthroplasty Cohort
1 other identifier
observational
250
1 country
2
Brief Summary
Total joint replacements are some of the most successful medical devices developed over the last fifty years. They enable millions of people to remain ambulatory and pain free, with minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements, and 25,000 total or partial shoulder replacements were performed in the United States (HCUP data). Future use will likely be even higher: it is estimated that by the year 2020, the population 65 and over in developed countries will increase by 71%. Existing studies do not provide adequate prospective data to evaluate long-term outcomes. HSS is a world leader in total joint replacement including total shoulder arthroplasty. However, there is no systematic follow-up or evaluation of patients who have their shoulders replaced here. The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing evaluation of the results of our patients over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2007
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 7, 2007
CompletedFirst Posted
Study publicly available on registry
September 11, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
February 12, 2026
November 1, 2025
20 years
September 7, 2007
February 11, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Patient Reported Outcome Measures (PROMs)
Patient reported outcomes (PROMs) at 1 year, 2 year, 5 year, 10 year follow-up time points. This information will be collected and maintained for use in future research studies with their own individually defined outcomes.
Collection of at Baseline, 6 Months, 1 Year, 2 Year, 5 Year and 10 Year
Intra Operative Data
Surgeon reported data
Collection of data on Day 0 (Date of Surgery)
Demographic data
Collection of patient information and demographic data
Collection of at Baseline, 6 Months, 1 Year, 2 Year, 5 Year and 10 Year
Eligibility Criteria
We will be asking all patients undergoing a total shoulder arthroplasty to participate.
You may qualify if:
- years or older and undergoing total shoulder arthroplasty at HSS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hospital for Special Surgery
New York, New York, 10021, United States
Hospital for Special Surgery
New York, New York, 10021, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Marx, MD
Hospital for Special Surgery, New York
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 7, 2007
First Posted
September 11, 2007
Study Start
April 1, 2007
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
February 12, 2026
Record last verified: 2025-11